Levamlodipine/Indapamide/Perindopril Arginine

左旋氨氯地平/吲达帕胺/精氨酸培哚普利

Report date: 2024/01/29 17:30:19
NME

Base Information

Drug NameLevamlodipine/Indapamide/Perindopril Arginine
Drug Alias NameS-06593S06593
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated L-type calcium channel blockersSymporters inhibitorsAngiotensin-converting enzyme inhibitors
TargetsVoltage-gated L-type calcium channelSymportersAngiotensin-converting enzyme
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Levamlodipine MaleateIndapamidePerindopril Arginine
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesServier (Ireland) Industries Ltd(Sii)Institut De Recherches Internationales ServierLes Laboratoires Servier +[4] 
Inactive CompaniesN/A
Active IndicationsEssential HypertensionHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BX01
Related LinksN/A